Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:dateCreated
1999-10-20
pubmed:abstractText
1. The cardiac effects of the NO donors sodium nitroprusside (SNP), S-nitroso-N-acetyl-penicillamine (SNAP) and 3-morpholino-sydnonimine (SIN-1) were studied in frog fibres to evaluate the contribution of cyclic GMP-dependent mechanisms. 2. SNP and SNAP (0.1-100 microM) reduced the force of contraction in a concentration-dependent manner in atrial and ventricular fibres. This effect was associated with a reduction in the time to peak (TTP) and the time for half-relaxation of contraction (T). 3. SIN-1 (100 microM) also reduced the force of contraction in two-thirds of the atrial fibres. However, it exerted a positive inotropic effect in the remaining atrial fibres, as well as in most ventricular fibres. 4. The guanylyl cyclase inhibitor 1H-[1,2,4]oxidiazolo[4,3-a]quinoxaline-1-one (ODQ, 10 microM) antagonized the negative inotropic effects of SIN-1 (50 microM) and SNAP (25 microM) but had no effect on the positive inotropic response to SIN-1 (100 microM). 5. In the presence of SIN-1, superoxide dismutase (SOD, 50-200 U ml-1) either potentiated the negative inotropic effect or turned the positive inotropic effect of the drug into a negative effect. SOD had no effects when applied alone or in the presence of SNAP. 6. 6-Anilino-5,8-quinolinedione (LY 83583, 3-30 microM), a superoxide anion generator also known as a cyclic GMP-lowering agent, exerted a positive inotropic effect, which was antagonized by SOD (200-370 U ml-1) but not by ODQ (10 microM). 7. We conclude that SNP, SNAP and SIN-1 exert cyclic GMP-dependent negative inotropic effects, which are attributed to the generation of NO. In addition, SIN-1 and LY 83583 exert cyclic GMP-independent positive inotropic effects, which require the generation of superoxide anion.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/10381591-1415782, http://linkedlifedata.com/resource/pubmed/commentcorrection/10381591-1849885, http://linkedlifedata.com/resource/pubmed/commentcorrection/10381591-2246177, http://linkedlifedata.com/resource/pubmed/commentcorrection/10381591-2442398, http://linkedlifedata.com/resource/pubmed/commentcorrection/10381591-2477870, http://linkedlifedata.com/resource/pubmed/commentcorrection/10381591-2484692, http://linkedlifedata.com/resource/pubmed/commentcorrection/10381591-2968192, http://linkedlifedata.com/resource/pubmed/commentcorrection/10381591-4538490, http://linkedlifedata.com/resource/pubmed/commentcorrection/10381591-7554131, http://linkedlifedata.com/resource/pubmed/commentcorrection/10381591-7589219, http://linkedlifedata.com/resource/pubmed/commentcorrection/10381591-7860763, http://linkedlifedata.com/resource/pubmed/commentcorrection/10381591-7902837, http://linkedlifedata.com/resource/pubmed/commentcorrection/10381591-7913042, http://linkedlifedata.com/resource/pubmed/commentcorrection/10381591-7923362, http://linkedlifedata.com/resource/pubmed/commentcorrection/10381591-7923615, http://linkedlifedata.com/resource/pubmed/commentcorrection/10381591-8380162, http://linkedlifedata.com/resource/pubmed/commentcorrection/10381591-8382691, http://linkedlifedata.com/resource/pubmed/commentcorrection/10381591-8594898, http://linkedlifedata.com/resource/pubmed/commentcorrection/10381591-8603511, http://linkedlifedata.com/resource/pubmed/commentcorrection/10381591-8615783, http://linkedlifedata.com/resource/pubmed/commentcorrection/10381591-8643623, http://linkedlifedata.com/resource/pubmed/commentcorrection/10381591-8653845, http://linkedlifedata.com/resource/pubmed/commentcorrection/10381591-8680744, http://linkedlifedata.com/resource/pubmed/commentcorrection/10381591-8700100, http://linkedlifedata.com/resource/pubmed/commentcorrection/10381591-8759239, http://linkedlifedata.com/resource/pubmed/commentcorrection/10381591-8781470, http://linkedlifedata.com/resource/pubmed/commentcorrection/10381591-8894977, http://linkedlifedata.com/resource/pubmed/commentcorrection/10381591-8928861, http://linkedlifedata.com/resource/pubmed/commentcorrection/10381591-8944624, http://linkedlifedata.com/resource/pubmed/commentcorrection/10381591-9190870, http://linkedlifedata.com/resource/pubmed/commentcorrection/10381591-9201028, http://linkedlifedata.com/resource/pubmed/commentcorrection/10381591-9257916, http://linkedlifedata.com/resource/pubmed/commentcorrection/10381591-9351463, http://linkedlifedata.com/resource/pubmed/commentcorrection/10381591-9369347, http://linkedlifedata.com/resource/pubmed/commentcorrection/10381591-9388576, http://linkedlifedata.com/resource/pubmed/commentcorrection/10381591-9421291, http://linkedlifedata.com/resource/pubmed/commentcorrection/10381591-9422697, http://linkedlifedata.com/resource/pubmed/commentcorrection/10381591-9452441, http://linkedlifedata.com/resource/pubmed/commentcorrection/10381591-9502194, http://linkedlifedata.com/resource/pubmed/commentcorrection/10381591-9559908
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
0022-3751
pubmed:author
pubmed:issnType
Print
pubmed:day
15
pubmed:volume
518 ( Pt 2)
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
449-61
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1999
pubmed:articleTitle
Positive and negative inotropic effects of NO donors in atrial and ventricular fibres of the frog heart.
pubmed:affiliation
Laboratoire de Cardiologie Cellulaire et Moleculaire, INSERM U-446, Universite Paris-Sud, Faculte de Pharmacie, F-92296 Châtenay-Malabry, France.
More...